iOmx Therapeutics
PrivateLast Round
Series B
Oct 5, 2021
Total Funding Raised
$120.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iOmx Therapeutics is a biopharmaceutical company that develops cancer immunotherapies by targeting novel immune checkpoints on tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iOmx Therapeutics Comparables
Compare iOmx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CatalYm | 83% | |
| Ipsen | 81% | |
| ImmunOs Therapeutics | 77% |
iOmx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 5, 2021 | ||||
| Series A | Sep 22, 2016 |
Key People
Founding team and executive leadership
iOmx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Series A |
| MIG Capital | Series B |
| M Ventures | Series A, Series B |
| MPM BioImpact | Series A |
| Sofinnova Partners | Series B, Series A |
| Wellington Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 47% MoM.
- Sep 22, 2016
$45M round led by MPM BioImpact, MPM Capital, and Sofinnova Partners.
iOmx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about iOmx Therapeutics's valuation, stock price, and market status.
Is iOmx Therapeutics a public or private company?
iOmx Therapeutics is a private company.
What is the current stock price of iOmx Therapeutics?
iOmx Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is iOmx Therapeutics worth (valuation)?
Valuation information for iOmx Therapeutics is not publicly available.
Can I buy iOmx Therapeutics stock?
iOmx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was iOmx Therapeutics's last funding round?
iOmx Therapeutics's most recent funding round was Series B on October 5, 2021.
Who are the main investors in iOmx Therapeutics?
Key investors in iOmx Therapeutics include MPM Capital, MIG Capital, Sofinnova Partners.
Will iOmx Therapeutics IPO soon?
No public IPO plans have been announced for iOmx Therapeutics.
How can I track iOmx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iOmx Therapeutics's secondary market activity and sign up for updates.